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A b s t r a c t - - A  single-step selection of  Chinese hamster V79 cells deficient in CTP synthetase 
(CTPS-) is presented. The underlying principle of  the direct selection is the differential and 
efficient killing of  synchronized wild-type cells through incorporation of  FH]uridine and 
[3H]thymidine. The CTPS- mutant cells were recovered by virtue of  their not engaging in 
DNA synthesis, because (1) CTPS- cells are deficient in CTP synthetase and thus are unable 
to convert [3H]UTP into [3H]CTP, which eventually is converted into FH]dCTP and 
incorporated into DNA; (2) the growth of  CTPS-  mutant cells was arrested as a result o f  
cytidine deprivation, thus escaping the killing by the incorporation of  FH]thymidine. The 
isolated mutant clones are auxotrophic for cytidine and are stable in phenotype with a 
reversion frequency of  less than 1 • 10 -z. The mutant cells have no or very low CTP 
synthetase activity when tested by in vitro CTP synthetase assay or by whole-cell FH]uridine 
labeling assay. This modified "tritium suicide" method combined with the S-phase cell 
synchronization could provide a powerful means for the recovery from the cell population of  
nondividing mutant cells that are auxotrophic for some special nutrient requirement. 
INTRODUCTION 
CTP synthetase (UTP:L-glutamine li- 
gase, EC 6.3.4.2) (abbreviated as CTPS) is a 
rate-limiting enzyme, catalyzing the irrevers- 
ible conversion of UTP to CTP. CTP in the de 
novo pathway may be regarded as the starting 
material for the subsequent synthesis of other 
cytidine and deoxycytidine nucleotides, in- 
cluding CTP and dCTP, which are the precur- 
sors for the synthesis of RNA and DNA. 
CTPS is thus indispensable in rapidly prolifer- 
ating cells. 
CTPS is an allosteric enzyme; high con- 
centration of CTP feedback inhibits CTPS 
(1). CTP feedback also inhibits aspartate 
transcarbamoylase and UDP reductase, thus 
reducing the rate of the de novo synthesis of 
UMP and the reduction rate of UDP to 
dUDP. This in turn decreases the intracellular 
pools of UTP and dTTP. 
CTPS variants from different mamma- 
lian cell lines have been selected (2-7). All 
these variants show altered CTPS activity 
that is no longer sensitive to the negative 
regulation of CTP. As a consequence, these 
variants have expanded CTP and dCTP pools. 
This renders these cells auxotrophic for thy- 
midine, resistant to the toxic effect of 1- 
/3-D-arabinofuranosyl-cytosine or 5-fluoroura- 
cil. More recently, Kelshall and Meuth (9) 
described the selection of CTP synthetase- 
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deficient mutants of Chinese hamster ovary 
(CHO) cells. The selection was based on the 
reversion of a thymidine auxotrophic mutant 
(Thy-1) to prototroph with a concomitant 
change to CTP synthetase deficiency. 
Deficiency of CTPS will make cell auxo- 
trophic for cytidine. A low intracellular pool 
of CTP, and hence a low level of dCTP as well, 
is expected to disturb the highly regulated 
pyrimidine metabolism. It might also affect 
DNA synthesis by changing the ratio of dCTP 
to dTTP, since an appropriate ratio of dCTP 
to dTTP ensures the fidelity of DNA replica- 
tion (2, 8, 10). The availability of CTPS- 
deficient mutants in a cell culture system may 
allow experiments to elucidate the role of this 
enzyme in pyrimidine metabolism, and facili- 
tate other studies such as the mapping of the 
human CTPS gene. 
MATERIALS AND METHODS 
Chemicals. [5-3H]Uridine (28 Ci /  
mmol) was purchased from Amersham Cor- 
poration (Buckinghamshire, England, United 
Kingdom). [methyl-3H]Thymidine was pur- 
chased from New England Nuclear (Boston, 
Massachusetts). N- (Phosphonacetyl)-L-as- 
partate (PALA) was obtained from Calbio- 
chem (La Jolla, California). [5-3H]UTP was 
obtained from ICN Radiochemicals (Irvine, 
California). Ethyl methane sulfonate (EMS) 
was purchased from Sigma Chemical Com- 
pany (St. Louis, Missouri). 
Cells and Media. The cells used in this 
study were V79 Chinese hamster lung fibro- 
blasts. The growth medium for all the experi- 
ments was Eagle's minimum essential me- 
dium (MEM with Earles' salt), supplemented 
with twofold of nonessential amino acids, 1.5- 
fold of essential amino acids and vitamins, and 
5% fetal calf serum (FCS) (Gibco Lab., 
Grand Island, New York). In some experi- 
ments, dialyzed FCS was substituted for FCS 
to ensure that no exogenous nucleosides were 
present. 
Isolation of  Cytidine-Requiring Vari- 
ants. Chinese hamster V79 cells were mutage- 
nized with EMS (300 #g/ml) in MEM for 18 
h. The medium was removed, and a new 
medium was added that contained 5% dia- 
lyzed FCS, 1 • 10 -4 M hypoxanthine, 1 • 
10 -5 M thymidine, 1 x 10 -6 M aminopterin 
(HAT medium), 1 x 10-4M PALA, 1 • 10 4 
M uridine, and 1 x 10 -4 M cytidine. Five days 
later, the cells were dispersed at a density of 
10 6 cells per 9-cm culture dish in a growth 
medium supplemented with 5% dialyzed FCS 
and 1 x 10 -4 M cytidine, but deficient in the 
essential amino acid methionine. Twenty-four 
hours later, a second cell synchronization step 
was introduced by changing the cells to a new 
medium containing 5% FCS and 2 mM 
hydroxyurea, but without cytidine. Ten hours 
later, the medium was removed and a new 
medium containing [5-3H]uridine (1 #Ci/ml) 
was added; the medium still did not contain 
any cytidine. After an 8-h exposure to the 
radioactive chemicals, the medium was 
removed, the dish was washed twice with 
phosphate-buffered saline (PBS), and a new 
medium containing 1 • 10 4 M cytidine was 
added. This medium was renewed the next 
day. Cell colonies that appeared after approxi- 
mately four to five weeks were cloned and 
tested for their dependence on cytidine. 
Measurement of  Colony-Forming Abil- 
ity in Various Media. To determine the ability 
of cells to form colonies in different media, 
200 cells were seeded in quadruplicate into 
60-ram culture dishes. After 7-10 days, the 
dishes were stained, and colonies were 
counted. 
Whole-Cell [3H] Uridine-Labeling As- 
say. Wild-type V79 and putative mutant cells, 
each at 2 • 10 6 cells per 60-mm culture dish, 
were labeled with 5 #Ci of [5-3H]uridine per 
milliliter of growth medium for 5 h. The cells 
were then collected by trypsinization, soni- 
cated, and heated to denature the macromole- 
cules. After centrifugation, the supernatant 
containing nucleotides was treated for 5 hr 
with alkaline phosphatase and phosphodies- 
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terase, which convert nucleotides to nucleo- 
sides. The enzyme reaction was terminated by 
heating for 1 min in a 100~ water bath. It 
was followed by centrifugation to obtain clear 
supernatant, which contained nucleosides. 
Thin-layer chromatography was performed 
by spotting 10 #1 nucleoside solution on cellu- 
lose F sheet (Merck Company, West Ger- 
many) and developed in a solvent solution 
containing isopropanol, concentrated HC1, 
and water. The spots corresponding to uridine 
and cytidine were cut out and the radioactiv- 
ity was counted. 
CPT Synthetase Assay. The assay was 
performed using a modified procedure of 
McLaren and Chu (11). Exponentially grow- 
ing cells were harvested by trypsinization and 
washed with PBS by centrifugation. The cells 
were resuspended at 1 x 108 cells/ml in 30 
mM Tris HC1, pH 7.5, plus 50 mM L-gluta- 
mine and 50 mM /3-mercaptoethanol, and 
disrupted by Ystral homogenizer (Ystral, 
West Germany). After centrifugation at 
100,000 g for 60 min, the supernatant was 
either used immediately or frozen in aliquots 
at -70~  
The reaction mixture in a volume of 
25-~1 contained 100 mM Tris HC1, pH 7.5, 8 
mM ATP, 0.2 mM GTP, 0.2 mM UTP, 25 
mM /3-mercaptoethanol, 24 mM MgC12, 1 
mM EDTA, 10 mM NaF, 48 mM L-gluta- 
mine, and 0.2 mM [3H]UTP (1 izCi). After 
incubation at 37~ for 60 min, 5 #1 of the 
reaction mixture was withdrawn and spotted 
immediately on polyethyleneimine-cellulose 
(PEI-cellulose) sheet (Merck). The sheet was 
then developed in 0.45 N HC1, and the spots 
corresponding to CTP and UTP were cut off 
and the radioactivity was counted. 
RESULTS 
Isolation of Cytidine-Requiring Mu- 
tants. Figure 1 may help to elucidate the 
principle underlying our selection of cytidine- 
requiring mutants. Tritium-labeled uridine 
transported into the cells is first phosphory- 
de novo 
CTP UTP synthesis 
l s y n t h e t a s e  t 1 
Cyd~ CMP~ CDP UDP ~UMP~ Urd 
dCyd~dCMP~dCDP dUDP 
dUMP 
d T M P ~ d T h d  
dTDP 
dCTP dTTP 
Fig. 1. Pyrimidine metabolism. 
lated by uridine kinase into UMP, which is 
then converted into UDP and UTP. Via the 
action of CTPS, [3H]UTP is converted into 
[3H]CTP, which later follows the path of 
deoxycytidine metabolism and converted into 
[3H]dCTP which is then incorporated into 
DNA. Thus, when cultured with [3H]uridine, 
the cells that incorporate tritium into DNA 
will die, whereas the cells that have defects in 
the pathways of uridine and cytidine will 
survive. The defects may involve mainly three 
enzymes, i.e., uridine kinase, UDP reductase, 
or CTPS. To avoid the selection of uridine 
kinase-deficient mutant, we first grew V79 
cells in medium containing 1 x 10 -4 M uri- 
dine and 1 x 10 4 M PALA. PALA is a 
strong inhibitor of aspartate transcarbamoy- 
lase (12) and thus blocks the de novo synthesis 
of UMP. In the presence of PALA and urid- 
ine, only those cells with intact uridine kinase 
activity can survive. However, following mul- 
tiround exposures of V79 cells to [5-3H]uri - 
dine, we did not obtain any surviving colonies 
that were cytidine auxotrophs. We reasoned 
that it could be the result of the large amount 
incorporation of [3H]UTP into RNA or to the 
long pathway of [3H]uridine to [3H]dCTP to 
DNA. We thus devised a short labeling 
scheme. Accordingly, V79 cells were mutage- 
nized with EMS. During the five days of 
mutation expression period, the medium con- 
tained uridine, PALA, cytidine, and HAT. 
The HAT medium was used to kill those cells 
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deficient in thymidine kinase. The cells were 
then synchronized twice, once by methionine 
starvation and then by hydroxyurea treat- 
ment. Hydroxyurea blocks the cell population 
at the border of G1 and S phases of the cell 
cycle (13). During the 10-h treatment with 
hydroxyurea, the cells were also deprived of 
cytidine. The cells were allowed to enter DNA 
synthesis phase by medium change; the 
medium contained [3H]uridine and [3H]thy- 
midine, but still without cytidine. Eight hours 
later the medium was removed, and the cul- 
ture dishes were washed twice with PBS, and 
a new medium containing 1 x 1 0  - 4  M of 
cytidine and 1 x 10 6 M of thymidine was 
added. The medium containing cytidine was 
changed the next day. In two separate experi- 
ments using EMS as the mutagenic agent, we 
isolated three clones that were cytidine auxo- 
trophs. The average frequency of occurrence 
was 1.8 x 10 -7. We did not find any sponta- 
neous cytidine auxotrophs from three experi- 
ments using no mutagen. 
Growth Characteristics of Cytidine- 
Dependent Mutant. The cytidine-requiring 
phenotype in the three clones, CTPS-1, 
CTPS-2, and CTPS-3, was stable on culture 
for more than 13 months. The clones are 
totally dependent on cytidine; neither uridine, 
thymidine, nor deoxycytidine could support 
cell growth (Table 1). The plating efficiency 
of the mutants in 1 x 1 0  - 4  M cytidine was 
100%, they also grew well in 1 x 10 -3 M 
cytidine, whereas V79 wild-type cells grew 
poorly in 1 • 10 3 M cytidine. This character- 
istic eliminates any revertant ceils arising in 
the mutant cell population. No cell survived to 
form a colony from up to 107 viable mutant 
cells that were plated in medium deficient in 
cytidine. The reversion frequency was, there- 
fore, less than 1 x 10 -7. Since the de novo 
synthesis of cytidine nucleotides is via CTPS, 
and since there is no other pathway except the 
salvage pathway by which cytidine is phos- 
phorylated, these results suggest that the 
mutant isolates must have defect in CTP 
synthesis. 
Initially all the three mutant clones grew 
slowly. At the very beginning we had to wait 
for up to one month for the isolation of variant 
clones. Once they were isolated and gradually 
adapted to the growth medium containing 1 • 
10 -3 M or 1 x 1 0  - 4  M cytidine, the growth 
rates increased. CTPS-1 cells have an average 
generation time of approximately 20 h as 
compared to the 16 h for the wild-type cells. 
Karyotype analysis of the selected 
CTPS-  mutants showed that a modal chro- 
mosome number was 20, which is the same as 
in the wild-type cell line. 
CTP Synthetase Activity. The growth 
characters suggest that the cytidine-requiring 
phenotypes appear to be due to the loss of 
CTPS activity. This is verified by the CTPS 
assay using crude cell extract. No CTPS 
activity was detected in all three variant cell 
lines, while the wild-type cells were found to 
exhibit normal CTPS activity (an average of 
4.8 nmol CTP formed/mg protein/h). This is 
further confirmed by a whole-cell [3H]uri- 
dine-labeling assay (see Materials and Meth- 
ods). Radioactivity from the mutant cell line 
(CTPS-1) was found only in the uridine cutoff 
but not in the cytidine cutoff, while the wild- 
type cells exhibit radioactivity in both nucleo- 
side spots (Table 2). The result indicates that 
CTPS-1 cells have very low CTPS activity in 
vivo to convert uridine nucleotides into cyti- 
dine nucleotides. 
DISCUSSION 
The "tritium suicide" method has been 
used successfully for the selection of mutants 
that are unable to incorporate 3H-labeled 
compounds into DNA. For instance, Urlaub 
and Chasin (14) used [3H]deoxyuridine as the 
selective agent to select for Chinese hamster 
cell mutants deficient in dihydrofolate reduc- 
tase activity. Ayasawa et al. (15) also used 
[3H]deoxyuridine to select for mouse FM3A 
cell mutants defective in thymidylate synthe- 
tase. However, in those cases, multiround 
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Table 2. Whole-Cell [3H]Uridine-Labeling Assay of 
V79 Wild-Type and CTPS-1 Mutant Cells a 
Radioactivity (%) 
Cell line Cytidine Uridine 
V79 8.55 86.90 
CTPS- 1 0.40 97.53 
aSee Materials and Methods for details of the experi- 
ment. 
were needed. Furthermore, in addition to the 
desired mutant cells, a lot of kinase-deficient 
mutants unable to phosphorylate the radioac- 
tive compounds were found, making the selec- 
tion inefficient. 
In the present selection scheme, three 
considerations are deemed crucial to its suc- 
cess. In the first place, we incorporated two 
selective formulations to kill cells deficient in 
either uridine kinase or thymidine kinase from 
the mutagenized cell population, thus avoid- 
ing the recovery of undesired mutants. Sec- 
ond, we combined the tritium suicide method 
with the cell synchronization at the S phase to 
facilitate the incorporation of radioactive pre- 
cursors for D N A  synthesis and to selectively 
eliminate wild-type cells in one strike. In this 
manner, we avoided the laborious cycles of 
cell labeling and growing the surviving cells. 
Those cells survived mainly because they were 
not in the S phase of the cell cycle and hence 
were not killed by the tritium. Third, by 
depriving the mutant CTPS cells of the 
needed cytidine, the growth and the D N A  
synthesis of these cells were arrested tempo- 
rarily. The putative mutants can then be 
rescued upon the addition of cytidine. 
In mammals,  the location of the genetic 
locus specifying CTPS (ctps) is unknown. I f  
the gene is autosomal, in order to obtain a 
homozygous recessive mutant with a complete 
enzyme deficiency, a double hit by mutagen is 
usually necessary. The frequency may be as 
low as 1 • 10 -7 (14, 16). In our case, the V79 
cell population did not spontaneously give rise 
to a mutant lacking CTPS activity. The fre- 
quency of occurrence of C T P S -  mutant in 
EMS-induced cell population was also very 
low. These facts suggest that there might be at 
least two wild-type alleles for the ctps locus in 
this pseudodiploid cell line (17). 
In view of the rate-limiting nature of 
CTPS, one might expect that a deficiency of 
CTPS would have a profound effect on the 
highly regulated pyrimidine metabolism. 
That  this seems to be the case is shown at least 
by the slow-growing nature of the three 
selected CTPS mutants. Moreover, in a pre- 
liminary experiment, we found that CTPS-1 
cells in the absence of cytidine are more 
sensitive to UV light as compared to the 
wild-type cells. A CTPS-deficient mutant, 
together with a CTPS-amplified mutant,  
which we have isolated several clones, should 
be of great value in investigating the mecha- 
nism of CTP regulating the pyrimidine 
metabolism. The mutants should also provide 
a system for the study of molecular somatic 
genetics. Using a C T P S -  mutant line and a 
normal human lymphoblastoid line, we have 
obtained hybrid clones that are cytidine proto- 
trophs. We are now in the process of mapping 
the human gene coding CTPS. 
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